A detailed history of Tactive Advisors, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Tactive Advisors, LLC holds 14,483 shares of PACB stock, worth $28,676. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,483
Previous 18,437 21.45%
Holding current value
$28,676
Previous $22.9 Million 18.91%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$1.17 - $1.69 $4,626 - $6,682
-3,954 Reduced 21.45%
14,483 $18.5 Million
Q2 2025

Aug 18, 2025

BUY
$0.91 - $1.45 $16,777 - $26,733
18,437 New
18,437 $22.9 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $445M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Tactive Advisors, LLC Portfolio

Follow Tactive Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tactive Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tactive Advisors, LLC with notifications on news.